Bill Text: IL HB5051 | 2023-2024 | 103rd General Assembly | Introduced

---

Bill Title: Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; or for specified prescription drugs, including insulin, human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone.

Spectrum: Partisan Bill (Democrat 6-0)

Status: (Introduced) 2024-04-24 - Added Co-Sponsor Rep. Lilian Jiménez [HB5051 Detail]

Download: Illinois-2023-HB5051-Introduced.html

---

103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB5051 Introduced , by Rep. Jenn Ladisch Douglass SYNOPSIS AS INTRODUCED:
215 ILCS 200/52 new
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; or for specified prescription drugs, including insulin, human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone.
LRB103 38175 RPS 68308 b
A BILL FOR
HB5051 LRB103 38175 RPS 68308 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Prior Authorization Reform Act is amended
by adding Section 52 as follows: